Covaxin booster dose can enhance efficacy against Delta, Omicron variants: ICMR Study

According to the research paper published by NIV Pune, Covaxin is the first vaccine in India to report safety and immunogenicity results from a booster clinical trial

from mint - Science https://ift.tt/lxujhOK
https://ift.tt/JO103NV